キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/25 | 2,899 | 2,917 | 2,881 | 2,909 | +22 | +0.8% | 44,900 |
2019/02/22 | 2,873 | 2,904 | 2,840 | 2,887 | -13 | -0.4% | 63,700 |
2019/02/21 | 2,939 | 2,945 | 2,888 | 2,900 | -20 | -0.7% | 55,500 |
2019/02/20 | 2,941 | 2,950 | 2,908 | 2,920 | -11 | -0.4% | 36,200 |
2019/02/19 | 2,949 | 2,956 | 2,919 | 2,931 | -1 | ±0% | 36,300 |
2019/02/18 | 2,934 | 2,950 | 2,915 | 2,932 | +80 | +2.8% | 43,900 |
2019/02/15 | 2,880 | 2,880 | 2,810 | 2,852 | -49 | -1.7% | 57,300 |
2019/02/14 | 2,932 | 2,950 | 2,879 | 2,901 | -34 | -1.2% | 77,900 |
2019/02/13 | 2,988 | 2,988 | 2,895 | 2,935 | -24 | -0.8% | 53,800 |
2019/02/12 | 2,881 | 2,959 | 2,876 | 2,959 | +101 | +3.5% | 65,700 |
2019/02/08 | 2,830 | 2,866 | 2,822 | 2,858 | -20 | -0.7% | 48,200 |
2019/02/07 | 2,916 | 2,916 | 2,860 | 2,878 | -35 | -1.2% | 49,800 |
2019/02/06 | 3,010 | 3,010 | 2,909 | 2,913 | -73 | -2.4% | 64,000 |
2019/02/05 | 3,060 | 3,095 | 2,973 | 2,986 | -69 | -2.3% | 100,700 |
2019/02/04 | 2,943 | 3,060 | 2,883 | 3,055 | +74 | +2.5% | 108,300 |
2019/02/01 | 2,929 | 3,010 | 2,900 | 2,981 | +32 | +1.1% | 75,400 |
2019/01/31 | 2,969 | 2,969 | 2,924 | 2,949 | +21 | +0.7% | 59,200 |
2019/01/30 | 2,942 | 2,963 | 2,928 | 2,928 | -15 | -0.5% | 111,200 |
2019/01/29 | 2,887 | 2,958 | 2,874 | 2,943 | +56 | +1.9% | 71,200 |
2019/01/28 | 2,880 | 2,896 | 2,851 | 2,887 | -16 | -0.6% | 43,000 |
2019/01/25 | 2,890 | 2,937 | 2,885 | 2,903 | -1 | ±0% | 61,500 |
2019/01/24 | 2,853 | 2,920 | 2,850 | 2,904 | +47 | +1.6% | 59,800 |
2019/01/23 | 2,853 | 2,880 | 2,844 | 2,857 | -20 | -0.7% | 42,900 |
2019/01/22 | 2,914 | 2,914 | 2,868 | 2,877 | -14 | -0.5% | 32,500 |
2019/01/21 | 2,886 | 2,896 | 2,854 | 2,891 | +22 | +0.8% | 59,400 |
2019/01/18 | 2,834 | 2,925 | 2,834 | 2,869 | +36 | +1.3% | 63,300 |
2019/01/17 | 2,843 | 2,867 | 2,760 | 2,833 | -9 | -0.3% | 87,100 |
2019/01/16 | 2,840 | 2,876 | 2,826 | 2,842 | +11 | +0.4% | 57,900 |
2019/01/15 | 2,804 | 2,870 | 2,804 | 2,831 | -43 | -1.5% | 54,300 |
2019/01/11 | 2,959 | 2,975 | 2,859 | 2,874 | -52 | -1.8% | 57,800 |
2019/01/10 | 2,923 | 2,934 | 2,887 | 2,926 | -29 | -1% | 60,000 |
2019/01/09 | 2,894 | 2,975 | 2,894 | 2,955 | +114 | +4% | 95,100 |
2019/01/08 | 2,852 | 2,870 | 2,819 | 2,841 | -17 | -0.6% | 92,400 |
2019/01/07 | 2,901 | 2,917 | 2,852 | 2,858 | +35 | +1.2% | 79,000 |
2019/01/04 | 2,829 | 2,882 | 2,795 | 2,823 | +22 | +0.8% | 101,500 |
2018/12/28 | 2,822 | 2,822 | 2,781 | 2,801 | -37 | -1.3% | 51,300 |
2018/12/27 | 2,725 | 2,849 | 2,725 | 2,838 | +174 | +6.5% | 109,600 |
2018/12/26 | 2,667 | 2,697 | 2,628 | 2,664 | +8 | +0.3% | 103,200 |
2018/12/25 | 2,824 | 2,824 | 2,637 | 2,656 | -197 | -6.9% | 97,200 |
2018/12/21 | 2,920 | 2,923 | 2,816 | 2,853 | -70 | -2.4% | 119,500 |
2018/12/20 | 2,988 | 3,010 | 2,920 | 2,923 | -112 | -3.7% | 100,400 |
2018/12/19 | 3,055 | 3,065 | 3,020 | 3,035 | -25 | -0.8% | 84,400 |
2018/12/18 | 3,160 | 3,215 | 3,045 | 3,060 | -155 | -4.8% | 139,200 |
2018/12/17 | 3,215 | 3,225 | 3,170 | 3,215 | -10 | -0.3% | 71,400 |
2018/12/14 | 3,255 | 3,280 | 3,220 | 3,225 | -35 | -1.1% | 92,400 |
2018/12/13 | 3,250 | 3,280 | 3,235 | 3,260 | +20 | +0.6% | 98,000 |
2018/12/12 | 3,160 | 3,255 | 3,160 | 3,240 | +10 | +0.3% | 112,100 |
2018/12/11 | 3,345 | 3,350 | 3,230 | 3,230 | -95 | -2.9% | 79,100 |
2018/12/10 | 3,360 | 3,390 | 3,310 | 3,325 | -105 | -3.1% | 62,800 |
2018/12/07 | 3,455 | 3,495 | 3,405 | 3,430 | -10 | -0.3% | 61,700 |
1601~
1650
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム